$5.04
+0.30 (+6.33%)
Open$4.71
Previous Close$4.74
Day High$5.11
Day Low$4.60
52W High$5.21
52W Low$3.06
Volume—
Avg Volume78.8K
Market Cap90.45M
P/E Ratio—
EPS$-1.91
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+648.2% upside
Current
$5.04
$5.04
Target
$37.71
$37.71
$24.55
$37.71 avg
$48.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.69M | 23.13M | 22.16M |
| Net Income | 4.47M | 4.40M | 4.69M |
| Profit Margin | 18.9% | 19.1% | 21.2% |
| EBITDA | 8.95M | 8.70M | 7.31M |
| Free Cash Flow | 3.30M | 3.54M | 2.93M |
| Rev Growth | +11.0% | +7.8% | +15.1% |
| Debt/Equity | 0.08 | 0.09 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |